Skip to main content
Phillip Palmbos, MD, Oncology, Ann Arbor, MI

PhillipLeePalmbosMDPhD

Oncology Ann Arbor, MI

Genitourinary Oncology, Hematologic Oncology

Physician

Dr. Palmbos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Palmbos' full profile

Already have an account?

  • Office

    1500 E Medical Center Dr
    Ann Arbor, MI 48109
    Phone+1 734-936-4000

Education & Training

  • University of Michigan
    University of MichiganFellowship, Hematology and Medical Oncology, 2010 - 2015
  • University of Michigan
    University of MichiganResidency, Internal Medicine, 2008 - 2010
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 2008

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2011 - 2027
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications  
    Petros Grivas, Phillip Palmbos, Ganesh Palapattu, Jeffrey S Montgomery, Alon Z Weizer, European Urology

Press Mentions

  • Considering Neoadjuvant Chemotherapy Options in Bladder Cancer
    Considering Neoadjuvant Chemotherapy Options in Bladder CancerJune 17th, 2016
  • Swimmers Take a Plunge in Detroit River to Raise Money for Cancer Research
    Swimmers Take a Plunge in Detroit River to Raise Money for Cancer ResearchJuly 11th, 2021
  • Damon Runyon Cancer Research Foundation Awards $5.2 Million to Top Clinical Investigators
    Damon Runyon Cancer Research Foundation Awards $5.2 Million to Top Clinical InvestigatorsAugust 8th, 2024